1215 related articles for article (PubMed ID: 10861319)
21. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn BM; Winiarski J; Ljungman P; Aschan J
Bone Marrow Transplant; 1998 Oct; 22(8):755-61. PubMed ID: 9827972
[TBL] [Abstract][Full Text] [Related]
22. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
Ringdén O; Schaffer M; Le Blanc K; Persson U; Hauzenberger D; Abedi MR; Olerup O; Ljungman P; Remberger M
Biol Blood Marrow Transplant; 2004 Feb; 10(2):128-34. PubMed ID: 14750078
[TBL] [Abstract][Full Text] [Related]
23. Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings.
Ringdén O; Klaesson S; Sundberg B; Ljungman P; Lönnqvist B; Persson U
Bone Marrow Transplant; 1992 Jan; 9(1):19-25. PubMed ID: 1543946
[TBL] [Abstract][Full Text] [Related]
24. GVHD prophylaxis using low-dose cyclosporine improves survival in leukaemic recipients of HLA-identical sibling transplants.
Olsson R; Remberger M; Hassan Z; Omazic B; Mattsson J; Ringdén O
Eur J Haematol; 2010 Apr; 84(4):323-31. PubMed ID: 20002156
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
Aschan J; Ringdén O
Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
[TBL] [Abstract][Full Text] [Related]
26. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
[TBL] [Abstract][Full Text] [Related]
27. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
[TBL] [Abstract][Full Text] [Related]
28. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.
Laughlin MJ; Barker J; Bambach B; Koc ON; Rizzieri DA; Wagner JE; Gerson SL; Lazarus HM; Cairo M; Stevens CE; Rubinstein P; Kurtzberg J
N Engl J Med; 2001 Jun; 344(24):1815-22. PubMed ID: 11407342
[TBL] [Abstract][Full Text] [Related]
29. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
30. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
Gale RP; Horowitz MM
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
[TBL] [Abstract][Full Text] [Related]
31. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract][Full Text] [Related]
32. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
[TBL] [Abstract][Full Text] [Related]
33. Related cord blood transplants: the Eurocord experience from 78 transplants. Eurocord Transplant group.
Rocha V; Chastang C; Souillet G; Pasquini R; Plouvier E; Nagler A; Locatelli F; Saarinen U; Cornu G; Bernaudin F; Gluckman E
Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S59-62. PubMed ID: 9712497
[TBL] [Abstract][Full Text] [Related]
34. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.
Remberger M; Naseh N; Aschan J; Barkholt L; LeBlanc K; Svennberg P; Ringdén O
Bone Marrow Transplant; 2003 Jul; 32(2):217-23. PubMed ID: 12838288
[TBL] [Abstract][Full Text] [Related]
35. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients.
Kurtzberg J; Laughlin M; Graham ML; Smith C; Olson JF; Halperin EC; Ciocci G; Carrier C; Stevens CE; Rubinstein P
N Engl J Med; 1996 Jul; 335(3):157-66. PubMed ID: 8657213
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.
Jacobsohn DA; Hewlett B; Ranalli M; Seshadri R; Duerst R; Kletzel M
Bone Marrow Transplant; 2004 Nov; 34(10):901-7. PubMed ID: 15361908
[TBL] [Abstract][Full Text] [Related]
37. Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation.
Ochs LA; Miller WJ; Filipovich AH; Haake RJ; McGlave PB; Blazar BR; Ramsay NK; Kersey JH; Weisdorf DJ
Bone Marrow Transplant; 1994 Apr; 13(4):455-60. PubMed ID: 8019471
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.
Barrett AJ; Horowitz MM; Pollock BH; Zhang MJ; Bortin MM; Buchanan GR; Camitta BM; Ochs J; Graham-Pole J; Rowlings PA
N Engl J Med; 1994 Nov; 331(19):1253-8. PubMed ID: 7935682
[TBL] [Abstract][Full Text] [Related]
39. Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings.
Mehta J; Powles R; Horton C; Milan S; Singhal S; Treleaven J
Bone Marrow Transplant; 1995 Jun; 15(6):853-8. PubMed ID: 7581080
[TBL] [Abstract][Full Text] [Related]
40. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]